首页> 外文期刊>Clinical oncology >A Randomised Double-blind Placebo-controlled Trial to Determine the Effect of Cranberry Juice on Decreasing the Incidence of Urinary Symptoms and Urinary Tract Infections in Patients Undergoing Radiotherapy for Cancer of the Bladder or Cervix
【24h】

A Randomised Double-blind Placebo-controlled Trial to Determine the Effect of Cranberry Juice on Decreasing the Incidence of Urinary Symptoms and Urinary Tract Infections in Patients Undergoing Radiotherapy for Cancer of the Bladder or Cervix

机译:一项随机双盲安慰剂对照试验,用于确定蔓越莓汁对减少接受膀胱癌或宫颈癌放疗的患者的尿毒症和泌尿道感染的发生率。

获取原文
获取原文并翻译 | 示例
       

摘要

Aims: Radical pelvic radiotherapy is one of the main treatment modalities for cancers of the bladder and cervix. The side-effects of pelvic radiotherapy include urinary symptoms, such as urinary frequency and cystitis. The therapeutic effects of cranberry juice in the prevention and treatment of urinary tract infections in general are well documented. The purpose of this study was to evaluate the effectiveness of cranberry juice on the incidence of urinary tract infections and urinary symptoms in patients undergoing pelvic radiotherapy for cancer of the bladder or cervix. Materials and methods: The study was a placebo-controlled, double-blind design. Participants were randomised to receive cranberry juice, twice a day (morning and night) for the duration of their radiotherapy treatment and for 2 weeks after treatment (6 weeks in total) or a placebo beverage, for the same duration. Results: The incidence of increased urinary symptoms or urinary tract infections was 82.5% on cranberry and 89.3% on placebo (P= 0.240, adjusted odds ratio [cranberry/placebo] 0.48, 95% confidence interval 0.14-1.63). Conclusions: The power of the study to detect differences was limited by the below target sample size and poor compliance. Further research is recommended, taking cognisance of the factors contributing to the limitations of this study.
机译:目的:盆腔根治性放射疗法是治疗膀胱癌和子宫颈癌的主要方法之一。盆腔放疗的副作用包括泌尿系统症状,例如尿频和膀胱炎。一般来说,酸果蔓汁在预防和治疗尿路感染中的治疗作用已得到充分证明。这项研究的目的是评估蔓越莓汁对接受膀胱癌或子宫颈癌的盆腔放疗患者尿路感染和泌尿系统症状的发生率。材料和方法:这项研究是安慰剂对照的双盲设计。参与者被随机分配接受蔓越莓汁,每天两次(早上和晚上)接受放射治疗,并在接受治疗后2周(总共6周)或安慰剂饮料接受相同的持续时间。结果:蔓越莓的泌尿症状或尿路感染增加的发生率为82.5%,而安慰剂为89.3%(P = 0.240,调整后的优势比[蔓越莓/安慰剂]为0.48,95%置信区间为0.14-1.63)。结论:该研究检测差异的能力受到以下目标样本量和不良依从性的限制。建议进一步研究,要考虑到造成本研究局限性的因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号